Prelude Therapeutics (PRLD) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Prelude Therapeutics (PRLD) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Prelude Therapeutics | 322.24 Mn | 177.64 Mn | - | -26.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.08% |
| Dec 31, 2025 | -24.44% |
| Sep 30, 2025 | -23.20% |
| Jun 30, 2025 | -21.15% |
| Mar 31, 2025 | -12.42% |
| Dec 31, 2024 | -7.62% |
| Sep 30, 2024 | 8.82% |
| Jun 30, 2024 | 24.20% |
| Mar 31, 2024 | 35.80% |
| Dec 31, 2023 | 49.25% |
| Sep 30, 2023 | 29.51% |
| Jun 30, 2023 | 41.94% |
| Mar 31, 2023 | 30.30% |
| Dec 31, 2022 | 24.92% |
| Sep 30, 2022 | 59.04% |
| Jun 30, 2022 | 37.83% |
| Mar 31, 2022 | 56.91% |
| Dec 31, 2021 | 58.43% |
| Sep 30, 2021 | 98.33% |
| Dec 31, 2020 | 50.58% |